methylnitrosourea has been researched along with idoxifene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chander, SK; Coombes, RC; Dowsett, M; Jarman, M; Luqmani, Y; McCague, R; Newton, C | 1 |
| Bliss, J; Coombes, RC; Hewer, A; Jarman, M; Pace, P; Phillips, D | 1 |
2 other study(ies) available for methylnitrosourea and idoxifene
| Article | Year |
|---|---|
Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer.
Topics: Animals; Breast Neoplasms; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Estradiol Congeners; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen | 1991 |
Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.
Topics: Animals; DNA Adducts; Female; Liver; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Survival Analysis; Tamoxifen; Time Factors | 1997 |